Notable Call Options Activity in Anadys Pharmaceuticals

Loading...
Loading...
Shares of Anadys Pharmaceuticals
ANDS
are higher on the session by 250.10%, currently trading at $3.641. The stock has been moving largely higher over the past three months and is currently trading above the 50-day moving average. Options traders are focusing on calls today. A short while ago the December 2011 $2.00 call traded 740 times on open interest of 670 contracts. Anadys Pharmaceuticals just entered into and agreement to be acquired by Roche for $3.70 per share. Calls are outpacing puts today by 50 to 1. Anadys Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing medicines for the treatment of hepatitis C. The company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C.
Posted In: OptionsMarkets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...